Evidence map›Paper›PMID 38695869›Full record

ArticleCancer research2024

Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.

Jonathan H Sussman, Nathalia Kim, Samantha B Kemp, Daniel Traum, Takeshi Katsuda, Benjamin M Kahn, Jason Xu, Il-Kyu Kim, Cody Eskandarian, Devora Delman and 4 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Review
  4. Spatial Multiomics Reveal Insights Into ADC Efficacy.European journal of immunology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. The diversity of CD8Nature reviews. Immunology · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Jonathan H SussmanDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-3057-3550
Nathalia KimDepartment of Biomedical and Molecular Sciences, School of Computing, Queen's University, Kingston, Canada.ORCID 0009-0002-6445-5592
Samantha B KempDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-1505-4015
Daniel TraumDepartment of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-0195-5525
Takeshi KatsudaDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-3960-033X
Benjamin M KahnDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-2034-417X
Jason XuGraduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-9061-3593
Il-Kyu KimDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-4661-0133
Cody EskandarianDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0003-7223-5773
Devora DelmanDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-1283-6705
Gregory L BeattyDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-7165-5993
Klaus H KaestnerDepartment of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-1228-021X
Amber L SimpsonDepartment of Biomedical and Molecular Sciences, School of Computing, Queen's University, Kingston, Canada.ORCID 0000-0002-4387-8417
Ben Z StangerDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-0410-4037
Cancer Research Institute · USUniversity of Pennsylvania · USCalifornia University of Pennsylvania · USQueen's University · CA

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EDWARD J DELIKATNY · 1985 to 2026
$222.3M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Targeting the liver for immunotherapy in pancreatic cancerR01CA197916 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Gregory L Beatty · 2016 to 2026
$3.7M
Defining metabolic adaptations within the PDAC "arid" tumor microenvironmentR01CA252225 · NCI · WISTAR INSTITUTE · PI DANG, CHI V., STANGER, BEN Z · 2021 to 2025
$2.8M
Stromal and vascular inputs into pancreatic cancer tumor neighborhoodsR01CA276512 · NCI · UNIVERSITY OF PENNSYLVANIA · PI M. CELESTE SIMON, BEN Z STANGER · 2023 to 2026
$2.6M
Mechanisms and therapeutic targets of cancer metastasisR01CA245323 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BEATTY, GREGORY L · 2020 to 2024
$1.8M
National Institutes of Health (NIH) CA016520National Institutes of Health (NIH) CA197916NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA197916NCI NIH HHS R01 CA245323NCI NIH HHS R01 CA252225NCI NIH HHS R01 CA276512NIDDK NIH HHS P30 DK050306University of Pennsylvania Pancreatic Cancer Research Center
6 · The paper itself

Abstract

Oncogenesis and progression of pancreatic ductal adenocarcinoma (PDAC) are driven by complex interactions between the neoplastic component and the tumor microenvironment, which includes immune, stromal, and parenchymal cells. In particular, most PDACs are characterized by a hypovascular and hypoxic environment that alters tumor cell behavior and limits the efficacy of chemotherapy and immunotherapy. Characterization of the spatial features of the vascular niche could advance our understanding of inter- and intratumoral heterogeneity in PDAC. In this study, we investigated the vascular microenvironment of PDAC by applying imaging mass cytometry using a 26-antibody panel on 35 regions of interest across 9 patients, capturing more than 140,000 single cells. The approach distinguished major cell types, including multiple populations of lymphoid and myeloid cells, endocrine cells, ductal cells, stromal cells, and endothelial cells. Evaluation of cellular neighborhoods identified 10 distinct spatial domains, including multiple immune and tumor-enriched environments as well as the vascular niche. Focused analysis revealed differential interactions between immune populations and the vasculature and identified distinct spatial domains wherein tumor cell proliferation occurs. Importantly, the vascular niche was closely associated with a population of CD44-expressing macrophages enriched for a proangiogenic gene signature. Taken together, this study provides insights into the spatial heterogeneity of PDAC and suggests a role for CD44-expressing macrophages in shaping the vascular niche. Significance: Imaging mass cytometry revealed that pancreatic ductal cancers are composed of 10 distinct cellular neighborhoods, including a vascular niche enriched for macrophages expressing high levels of CD44 and a proangiogenic gene signature.

Indexed as

Carcinoma, Pancreatic DuctalImage CytometryPancreatic NeoplasmsTumor MicroenvironmentHumansHyaluronan ReceptorsNeovascularization, PathologicHyaluronan Receptors

Identifiers

PMID38695869
PMCPMC11250934
OpenAlexW4396597094

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.